Loading…

Characterizing a novel bacterial sirtuin protein in an intact protein system

Sirtuins, proteins that remove acyl‐modifications from lysine side chains, have many important medical and biological applications as they are involved in a wide range of cellular processes such as aging, transcriptional regulation through histone tail modification, and stress resistance. They have...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2019-04, Vol.33 (S1), p.781.11-781.11
Main Authors: Muroski, John, Fu, Janine, Orgazalek Loo, Rachel R, Loo, Joe A
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sirtuins, proteins that remove acyl‐modifications from lysine side chains, have many important medical and biological applications as they are involved in a wide range of cellular processes such as aging, transcriptional regulation through histone tail modification, and stress resistance. They have been suggested to mitigate damage caused by carbon stress and its associated non‐enzymatic modification of protein by reactive acyl‐CoA species. Protein hyperacylation has been associated with altered metabolic flux or reduced enzymatic activities. Syntrophus aciditrophicus, a bacterium existing in extreme conditions, displays unusually high levels of protein acylation, leading us to wonder whether sirtuins are present in this system to remove these acyl modifications. Sirtuin homologs have been found in these bacteria by genetic homology, but their substrate specificities and activities have not been studied. We developed a novel mass spectrometry based enzymatic assay to test the range of acyl groups S. aciditrophicus sirtuins could recognize and measured their reaction kinetics. Novel sirtuin homologs (Syn42, Syn1020) from S. aciditrophicus were expressed recombinantly. Insulin was chemically modified with acyl‐anhydrides corresponding to the desired acyl modification (e.g. acetic anhydride for acetyl‐modified insulin, propionic anhydride for propionyl‐modified insulin) as a proxy for an acyl‐modified substrate. Sirtuin (10 μM) was added to varyied concentrations of acyl‐insulin in ammonium acetate buffer (pH ~7.5), with excess NAD+. The reaction was halted at timepoints 1, 3, 5, 10, and 15 minutes by mixing with acetonitrile 1:1 and ubiquitin was added into the mixture as an internal standard for mass spectrometric quantitation. Assay contents were analyzed by mass spectrometry. We have shown that the novel sirtuin Syn42 acts on several acylations including butyryl, glutaryl, succinyl, and propionyllysines. In addition to determining acyl‐group substrate specificity, we were also able to measure Michaelis‐Menten kinetics, by plotting time courses of sirtuin enzymatic activity. For glutaryl‐modified insulin, the Km was determined to be 16.92 μM and the Kcat was determined to be 0.0022 sec−1, which are comparable to previous measurements of mammalian sirtuin SIRT1. In conclusion, we were able to identify and confirm the activity of novel sirtuin from a bacterial source. We were also able to determine its acyl‐group substrate specificity as well as its kinetic
ISSN:0892-6638
1530-6860
DOI:10.1096/fasebj.2019.33.1_supplement.781.11